Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Halozyme Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HALO.
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Other companies in Halozyme Therapeutics’s space includes: Exact Sciences (NASDAQ:EXAS), BeiGene (NASDAQ:ONC), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Halozyme Therapeutics has a consensus price target of $58.55.
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $56.45 last updated April 21, 2025 at 7:21 PM EDT.
There are no upcoming dividends for Halozyme Therapeutics.
Halozyme Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Halozyme Therapeutics.
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.